{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:55:38Z","timestamp":1790661338175,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jaip.2016.11.026","type":"journal-article","created":{"date-parts":[[2017,1,18]],"date-time":"2017-01-18T09:21:53Z","timestamp":1484731313000},"page":"1040-1049.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids"],"prefix":"10.1016","volume":"5","author":[{"given":"Theresa W.","family":"Guilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Colice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"van Aalderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirkje S.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Phipatanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth V.","family":"Hillyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrna B.","family":"Dolovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2016.11.026_bib1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.rmed.2011.03.012","article-title":"Retail sales of inhalation devices in European countries: so much for a global policy","volume":"105","author":"Lavorini","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0378-5173(78)90010-8","article-title":"Drug deposition of pressurized inhalation aerosols, II: influence of vapour pressure and metered volume","volume":"1","author":"Mor\u00e9n","year":"1978","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jaip.2016.11.026_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1183\/09031936.02.00218402","article-title":"Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability","volume":"19","author":"Giraud","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2016.11.026_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.rmed.2011.01.005","article-title":"Inhaler mishandling remains common in real life and is associated with reduced disease control","volume":"105","author":"Melani","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4104\/pcrj.2013.00084","article-title":"Asthma patients' inability to use a pressurised metered-dose inhaler (pMDI) correctly correlates with poor asthma control as defined by the global initiative for asthma (GINA) strategy: a retrospective analysis","volume":"22","author":"Levy","year":"2013","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2016.11.026_bib6","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/09031936.00166410","article-title":"What the pulmonary specialist should know about the new inhalation therapies","volume":"37","author":"Laube","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2016.11.026_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.rmed.2012.09.017","article-title":"Inhaler competence in asthma: common errors, barriers to use and recommended solutions","volume":"107","author":"Price","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1081-1206(10)61410-X","article-title":"Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults","volume":"93","author":"Melani","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.11.026_bib9","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2016.03.041","article-title":"Aerosol Drug Management Improvement Team (ADMIT). Systematic review of errors in inhaler use: has patient technique improved over time?","volume":"150","author":"Sanchis","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2016.11.026_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-8502(82)90002-7","article-title":"Design and characteristics of a portable breath-actuated particle size selective medical aerosol inhaler","volume":"13","author":"Corr","year":"1982","journal-title":"J\u00a0Aerosol Sci"},{"key":"10.1016\/j.jaip.2016.11.026_bib11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1378\/chest.127.1.335","article-title":"Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians\/American College of Asthma, Allergy, and Immunology","volume":"127","author":"Dolovich","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2016.11.026_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1081\/DDC-100104315","article-title":"Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI","volume":"27","author":"Williams","year":"2001","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.jaip.2016.11.026_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2125.1999.00900.x","article-title":"A\u00a0comparative analysis of the particle size output of beclomethasone diproprionate, salmeterol xinafoate and fluticasone propionate metered dose inhalers used with the Babyhaler, Volumatic and Aerochamber spacer devices","volume":"47","author":"Barry","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2016.11.026_bib14","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.2105013","article-title":"Systemic effect comparisons of six inhaled corticosteroid preparations","volume":"165","author":"Martin","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1081-1206(10)61997-7","article-title":"In\u00a0vitro deposition of fluticasone aerosol from a metered-dose inhaler with and without two common valved holding chambers","volume":"88","author":"Asmus","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2016.11.026_bib16","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1183\/09031936.98.12061346","article-title":"Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone","volume":"12","author":"Leach","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2016.11.026_bib17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1378\/chest.122.2.510","article-title":"Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers","volume":"122","author":"Leach","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2016.11.026_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/jamp.2014.1199","article-title":"Respiratory tract deposition of HFA-beclomethasone and HFA-fluticasone in asthmatic patients","volume":"29","author":"Leach","year":"2016","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.jaip.2016.11.026_bib19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/jam.2006.19.117","article-title":"Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers","volume":"19","author":"Leach","year":"2006","journal-title":"J\u00a0Aerosol Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.rmed.2005.09.027","article-title":"High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma","volume":"100","author":"Newman","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib21","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/jamp.2009.0783","article-title":"A\u00a0pilot study to assess lung deposition of HFA-beclomethasone and CFC-beclomethasone from a pressurized metered dose inhaler with and without add-on spacers and using varying breathhold times","volume":"23","author":"Leach","year":"2010","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.jaip.2016.11.026_bib22","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/jam.2005.18.379","article-title":"Influence of particle size and patient dosing technique on lung deposition of HFA-beclomethasone from a metered dose inhaler","volume":"18","author":"Leach","year":"2005","journal-title":"J\u00a0Aerosol Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/00003088-200645070-00007","article-title":"Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation","volume":"45","author":"Drollmann","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jaip.2016.11.026_bib24","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.rmed.2009.06.004","article-title":"Once-daily ciclesonide via metered-dose inhaler: similar efficacy and safety with or without a spacer","volume":"103","author":"Engelst\u00e4tter","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1164\/arrd.1984.129.5.723","article-title":"Use of spacers to facilitate inhaled corticosteroid treatment of asthma","volume":"129","author":"Toogood","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2016.11.026_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0091-6749(88)90911-6","article-title":"Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber","volume":"81","author":"Salzman","year":"1988","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.026_bib27","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1067\/mai.2000.111582","article-title":"Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma","volume":"106","author":"Vanden Burgt","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.026_bib28","unstructured":"National Asthma Council Australia. Australian Asthma Handbook Version 1.1 (2015), Choosing an inhaler device to suit the individual. Available from: http:\/\/www.asthmahandbook.org.au\/management\/devices\/device-choice. Accessed July 18,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bib29","unstructured":"Optimum Patient Care Research Database (OPCRD). Available from: http:\/\/optimumpatientcare.org\/opcrd\/. Accessed July 18,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(14)70008-6","article-title":"Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort","volume":"2","author":"Jones","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib31","unstructured":"Clinical Practice Research Datalink. Available from: http:\/\/www.cprd.com\/home\/. Accessed July 18,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bib32","unstructured":"The Clinical Practice Research Datalink. Boston Collaborative Drug Surveillance Program. Available from: http:\/\/www.bu.edu\/bcdsp\/gprd\/. Accessed July 18,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bib33","unstructured":"Respiratory Effectiveness Group (REG). Available from: http:\/\/www.effectivenessevaluation.org\/. Accessed July 18,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bib34","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1513\/AnnalsATS.201309-300RM","article-title":"Quality standards for real-world research: focus on observational database studies of comparative effectiveness","volume":"11","author":"Roche","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2016.11.026_bib35","unstructured":"Read Codes. Health & Social Care Information Centre. Available from: http:\/\/systems.hscic.gov.uk\/data\/uktc\/readcodes. Accessed July 18,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bib36","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200801-060ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice","volume":"180","author":"Reddel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib37","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.201411-2116LE","article-title":"Differential effects of inhaled corticosteroids in smokers\/ex-smokers and nonsmokers with asthma","volume":"191","author":"Roche","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaip.2015.04.012","article-title":"Small-particle inhaled corticosteroid as first-line or step-up controller therapy in childhood asthma","volume":"3","author":"van Aalderen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.11.026_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2013.02.008","article-title":"Asthma outcomes and costs of therapy with extrafine beclomethasone and fluticasone","volume":"132","author":"Colice","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.026_bib40","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaip.2016.06.009","article-title":"Long-acting beta-agonist in combination or separate inhaler as step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids","volume":"5","author":"Turner","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2016.11.026_bib41","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2016.4151","article-title":"Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010-2011","volume":"315","author":"Fleming-Dutra","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2016.11.026_bib42","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.rmed.2010.04.012","article-title":"Choosing inhaler devices for people with asthma: current knowledge and outstanding research needs","volume":"104","author":"Haughney","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib43","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/thx.46.12.891","article-title":"Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler","volume":"46","author":"Selroos","year":"1991","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2016.11.026_bib44","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/thx.2006.066837","article-title":"External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?","volume":"62","author":"Travers","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2016.11.026_bib45","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/S2213-2600(13)70199-1","article-title":"Integrating real-life studies in the global therapeutic research framework","volume":"1","author":"Roche","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib46","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1513\/AnnalsATS.201308-276RM","article-title":"Complementing the randomized controlled trial evidence base: evolution not revolution","volume":"11","author":"Price","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2016.11.026_bib47","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0169-409X(03)00083-8","article-title":"The influence of inhaler selection on efficacy of asthma therapies","volume":"55","author":"Barry","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jaip.2016.11.026_bib48","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/rmed.1999.0767","article-title":"Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI","volume":"94","author":"Lenney","year":"2000","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2016.11.026_bib49","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaci.2010.06.040","article-title":"Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study","volume":"126","author":"Price","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.026_bib50","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1365-2222.2011.03820.x","article-title":"Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study","volume":"41","author":"Barnes","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2016.11.026_bib51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1183\/09031936.00051106","article-title":"Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children","volume":"29","author":"Roller","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2016.11.026_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/CMPed.S4311","article-title":"Similar results in children with asthma for steady state pharmacokinetic parameters of ciclesonide inhaled with or without spacer","volume":"4","author":"Boss","year":"2010","journal-title":"Clin Med Insights Pediatr"},{"key":"10.1016\/j.jaip.2016.11.026_bib53","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.jaci.2010.01.034","article-title":"Factors that affect the efficacy of inhaled corticosteroids for infants and young children","volume":"125","author":"Amirav","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2016.11.026_bibE1","unstructured":"Optimum Patient Care Research Database (OPCRD). Available from: http:\/\/www.optimumpatientcare.org\/Html_Docs\/OPCRD.html. Accessed July 14,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bibE2","unstructured":"Clinical Practice Research Datalink. Available from: http:\/\/www.cprd.com\/home\/. Accessed July 14,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bibE3","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1513\/AnnalsATS.201309-300RM","article-title":"Quality standards for real-world research. Focus on observational database studies of comparative effectiveness","volume":"11","author":"Roche","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2016.11.026_bibE4","unstructured":"Respiratory Effectiveness Group (REG). Available from: http:\/\/www.effectivenessevaluation.org\/. Accessed July 14,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bibE5","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). Electronic Register of Studies. Available from: http:\/\/www.encepp.eu\/encepp\/studiesDatabase.jsp. Accessed July 14,\u00a02016."},{"key":"10.1016\/j.jaip.2016.11.026_bibE6","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP). The ENCePP Code of Conduct. Available from: http:\/\/www.encepp.eu\/code_of_conduct\/. Accessed July 14,\u00a02016."}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816305840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219816305840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:11:37Z","timestamp":1761973897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219816305840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2213219816305840"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2016.11.026","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2016.11.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}